Core Laboratories NV Company Profile (NYSE:CLB)

About Core Laboratories NV

Core Laboratories N.V. is a provider of reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company's services and products are directed toward enabling the Company's clients to improve reservoir performance and increase oil and gas recovery from their producing fields. The Company has over 70 offices in over 50 countries. The Company operates in three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and improve recovery of oil and gas from the Company's clients' reservoirs.

Industry, Sector and Symbol:

Sector: Oils/Energy
Industry: Oil & Gas Equipment & Services
Sub-Industry: N/A
Exchange: NYSE
Symbol: CLB
CUSIP:

Key Metrics:

Previous Close: $104.76
50 Day Moving Average: $113.25
200 Day Moving Average: $117.75
52-Week Range: $44,106,000.00 - $84.50
Trailing P/E Ratio: 55.58
Foreward P/E Ratio: 45.75
P/E Growth: 6.45
Market Cap: $4.62B
Outstanding Shares: 44,106,000
Beta: 1.56

Profitability:

Net Margins: 11.81%
Return on Equity: 344.55%
Return on Assets: 15.57%

Debt:

Debt-to-Equity Ratio: 1.25%
Current Ratio: 2.03%
Quick Ratio: 1.61%

Additional Links:

Companies Related to Core Laboratories NV:

Consensus Ratings for Core Laboratories NV (NYSE:CLB) (?)

Ratings Breakdown:	3 Sell Ratings, 10 Hold Ratings, 7 Buy Ratings
Consensus Rating:	Hold (Score: 2.20)
Consensus Price Target:	$120.13 (14.67% upside)

Analysts' Ratings History for Core Laboratories NV (NYSE:CLB)

Show:

Date	Firm	Action	Rating	Price Target
9/12/2016	Citigroup Inc.	Lower Price Target	Neutral	$118.00 -> $116.00
9/1/2016	Credit Suisse Group AG	Initiated Coverage	Neutral	$115.00
7/12/2016	JPMorgan Chase & Co.	Downgrade	Neutral -> Underweight
6/13/2016	KLR Group	Reiterated Rating	Buy	$166.00 -> $180.00
4/23/2016	Cowen and Company	Reiterated Rating	Hold
4/23/2016	Royal Bank Of Canada	Reiterated Rating	Buy
4/23/2016	Simmons	Reiterated Rating	Hold	$105.00 -> $115.00
4/22/2016	ABN Amro	Downgrade	Buy -> Sell
4/22/2016	Stephens	Boost Price Target	Equal Weight	$89.00 -> $98.00
4/19/2016	Morgan Stanley	Boost Price Target	Overweight	$120.00 -> $140.00
3/28/2016	Howard Weil	Boost Price Target		$112.00
2/10/2016	ING Group	Lower Price Target	Hold	$125.00 -> $112.00
2/2/2016	William Blair	Reiterated Rating	Outperform
1/30/2016	Scotiabank	Reiterated Rating	Sector Perform	$117.00 -> $105.00
1/29/2016	SunTrust Banks Inc.	Lower Price Target	Buy	$123.00 -> $109.00
1/29/2016	Iberia Capital	Lower Price Target	Outperform	$140.00 -> $115.00
1/26/2016	HSBC	Downgrade	Hold -> Reduce
1/11/2016	Oppenheimer Holdings Inc.	Initiated Coverage	Market Perform
11/30/2015	Guggenheim	Upgrade	Neutral -> Buy	$135.00
9/30/2015	Sterne Agee CRT	Lower Price Target	Neutral	$113.00 -> $108.00
10/15/2014	Evercore ISI	Initiated Coverage	Buy	$151.00

(Data available from 9/25/2014 forward)

Earnings History for Core Laboratories NV (NYSE:CLB)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/19/2016
7/20/2016	Q216	$0.35	$0.35	$146.37 million	$148.10 million	View	N/A
4/20/2016	Q116	$0.37	$0.37	$161.24 million	$153.65 million	View	N/A
1/27/2016	Q415	$0.65	$0.65	$179.48 million	$182.70 million	View	Listen
10/21/2015	Q315	$0.83	$0.83	$203.29 million	$197.27 million	View	Listen
7/22/2015	Q215	$0.77	$0.82	$195.13 million	$204.00 million	View	Listen
4/22/2015	Q115	$0.85	$0.86	$211.82 million	$213.64 million	View	N/A
1/28/2015	Q414	$1.54	$1.54	$280.18 million	$278.60 million	View	N/A
10/22/2014	Q314	$1.51	$1.53	$284.30 million	$276.14 million	View	Listen
7/23/2014	Q214	$1.34	$1.35	$269.70 million	$267.56 million	View	Listen
4/23/2014	Q114	$1.45	$1.35	$283.02 million	$262.90 million	View	Listen
1/30/2014	Q413	$1.40	$1.43	$278.55 million	$276.30 million	View	Listen
10/17/2013	Q313	$1.34	$1.36	$267.21 million	$273.16 million	View	N/A
7/17/2013	Q2 2013	$1.31	$1.32	$267.24 million	$263.14 million	View	Listen
4/17/2013	Q1 2013	$1.15	$1.22	$260.90 million	$260.90 million	View	Listen
1/30/2013	Q4 2012	$1.13	$1.17	$246.49 million	$254.46 million	View	Listen
10/17/2012		$1.10	$1.13			View	N/A
7/18/2012		$1.16	$1.16			View	N/A
4/18/2012		$1.07	$1.06			View	N/A
2/1/2012		$1.08	$1.09			View	N/A
10/19/2011		$0.99	$0.93			View	N/A
4/19/2011		$0.75	$0.77			View	N/A
2/9/2011		$0.81	$0.84			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Core Laboratories NV (NYSE:CLB)

Current Year EPS Consensus Estimate: $1.56 EPS
Next Year EPS Consensus Estimate: $2.29 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	6	$0.35	$0.75	$0.53
Q2 2016	3	$0.27	$0.72	$0.45
Q3 2016	3	$0.28	$0.77	$0.48
Q4 2016	3	$0.32	$0.76	$0.49
Q1 2017	2	$0.40	$0.81	$0.61
Q2 2017	2	$0.40	$0.88	$0.64
Q3 2017	2	$0.43	$0.97	$0.70
Q4 2017	2	$0.43	$1.03	$0.73

(Data provided by Zacks Investment Research)

Current Dividend Information for Core Laboratories NV (NYSE:CLB)

Annual Dividend:	$2.20
Dividend Yield:	2.10%
Dividend Growth:	25.20% (3 Year Average)
Payout Ratio:	117.65% (Based on Trailing 12 Months of Earnings) 141.03% (Based on Current Year Consensus EPS Estimate) 96.07% (Based on Next Year Consensus EPS Estimate)
Track Record:	6 Years of Consecutive Dividend Growth

Dividend History for Core Laboratories NV (NYSE:CLB)

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/7/2016	Quarterly	$0.55		7/14/2016	7/18/2016	8/15/2016
4/15/2016	Quarterly	$0.55		5/2/2016	5/4/2016	5/24/2016
1/11/2016	Quarterly	$0.55	2.28%	1/20/2016	1/22/2016	2/19/2016
10/13/2015	Quarterly	$0.55		10/21/2015	10/23/2015	11/24/2015
7/7/2015	quarterly	$0.55	2.02%	7/15/2015	7/17/2015	8/17/2015
1/12/2015		$0.55		1/21/2015	1/23/2015	2/20/2015
10/6/2014	quarterly	$0.50	1.39%	10/16/2014	10/17/2014	11/25/2014
7/8/2014	quarterly	$0.50		7/16/2014	7/18/2014	8/18/2014
4/14/2014	quarterly	$0.50	1.33%	4/23/2014	4/25/2014	5/23/2014
1/13/2014	quarterly	$0.50	1.05%	1/22/2014	1/24/2014	2/21/2014
10/8/2013	quarterly	$0.32	0.73%	10/16/2013	10/18/2013	11/20/2013
7/9/2013	quarterly	$0.32	0.82%	7/17/2013	7/19/2013	8/19/2013
4/15/2013	quarterly	$0.32	1.01%	4/24/2013	4/26/2013	5/24/2013
1/11/2013	quarterly	$0.32			1/22/2013	2/22/2013

(Data available from 1/1/2013 forward)

Insider Trading History for Core Laboratories NV (NYSE:CLB)

Insider Ownership Percentage: 1.00%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/2/2016	Jan Willem Sodderland	Director	Buy	300	$93.90	$28,170.00
5/12/2015	Michael C Kearney	Director	Sell	1,000	$128.52	$128,520.00
11/17/2014	Mark F Elvig	VP	Sell	1,000	$138.03	$138,030.00
7/28/2014	Richard L Bergmark	CFO	Buy	7,000	$147.31	$1,031,170.00
3/7/2014	Michael Kearney	Director	Sell	2,000	$193.00	$386,000.00
2/14/2014	Mark Elvig	VP	Sell	1,500	$186.64	$279,960.00
10/21/2013	Monty L Davis	COO	Sell	5,704	$197.33	$1,125,570.32
8/7/2013	Richard Bergmark	CFO	Sell	20,000	$149.58	$2,991,600.00
7/25/2013	Charles Brigham Miller	CAO	Sell	11,648	$147.81	$1,721,690.88
7/25/2013	Monty L Davis	COO	Sell	5,948	$149.12	$886,965.76

(Data available from 1/1/2013 forward)

Latest Headlines for Core Laboratories NV (NYSE:CLB)

Date	Headline
	Core Laboratories N.V. (NYSE:CLB) Had $22.494 In Cash And Short-Term Investments (NYSE:CLB) www.stocksdaily.net - September 24 at 4:05 PM
	Core Laboratories NV (NYSE:CLB) Had $22.494 In Cash And Short-Term Investments - Stocks Daily (NYSE:CLB) www.stocksdaily.net - September 24 at 8:29 AM
	Core Laboratories PT Lowered to $116.00 (CLB) - Petro Global News 24 (NYSE:CLB) petroglobalnews24.com - September 21 at 4:53 PM
	Core Lab Presents At Johnson Rice Energy Conference - PR Newswire (press release) (NYSE:CLB) www.prnewswire.com - September 21 at 4:53 PM
	CORE LABORATORIES N V Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NYSE:CLB) biz.yahoo.com - September 21 at 8:17 AM
	Core Lab Presents At Johnson Rice Energy Conference (NYSE:CLB) finance.yahoo.com - September 21 at 8:17 AM
	How SPN’s Current Valuation Compares to Its Peers’ (NYSE:CLB) marketrealist.com - September 21 at 8:17 AM
	Bullish Target For Core Laboratories N.V. (NYSE:CLB) At $150 - Investor Newswire (NYSE:CLB) www.investornewswire.com - September 19 at 5:01 PM
	Analysts Take Aim At This Stock's Earnings Estimates: Core Laboratories N.V. (NYSE:CLB) - Frisco Fastball (NYSE:CLB) friscofastball.com - September 19 at 5:01 PM
	Core Laboratories N.V. (NYSE:CLB) Held $22.494 In Cash And Short-Term Investments (NYSE:CLB) www.stocksdaily.net - September 16 at 4:07 PM
	Core Laboratories N.V. Common S (CLB) - Citigroup Holds Rating And Sets New Price Target - Finance Daily (NYSE:CLB) www.fidaily.com - September 12 at 4:06 PM
	Core Laboratories NV (NYSE:CLB) CFF Stands At $-180.302 Millions - Stocks Daily (NYSE:CLB) www.stocksdaily.net - September 10 at 8:55 AM
	ETF’s with exposure to Core Laboratories NV : September 9, 2016 (NYSE:CLB) www.capitalcube.com - September 9 at 4:07 PM
	Core Laboratories N.V. (NYSE:CLB) From The Analysts Point of View - National Daily Press (NYSE:CLB) www.nationaldailypress.com - September 9 at 9:04 AM
	Cramer: Keep Calm About Apache and Invest On (NYSE:CLB) realmoney.thestreet.com - September 9 at 9:04 AM
	The Best Oil Stock You Can Buy (NYSE:CLB) www.fool.com - September 4 at 8:51 AM
	Coverage initiated on Core Labs by Credit Suisse (NYSE:CLB) finance.yahoo.com - September 1 at 4:10 PM
	Credit Suisse Likes Core Laboratories Better As A Company Than As A Stock (NYSE:CLB) www.benzinga.com - September 1 at 11:40 AM
	Shares of CLB Now Oversold (NYSE:CLB) www.nasdaq.com - September 1 at 11:40 AM
	Core Laboratories N.V. (NYSE:CLB) Gets 0 Recommendations To Sell - Investor Newswire (NYSE:CLB) www.investornewswire.com - August 25 at 4:17 PM
	Core Laboratories NV (NYSE:CLB) Cash and Short – Term Investments Is Reported At $22.494 Millions - Stocks Daily (NYSE:CLB) www.stocksdaily.net - August 20 at 7:58 AM
	Wal-Mart records biggest same-store sales increase in four years - Petro Global News 24 (NYSE:CLB) petroglobalnews24.com - August 19 at 11:36 AM
	Retail & Analyst Ratings Forecasts on Core Laboratories N.V. (NYSE:CLB) - Post News (NYSE:CLB) www.kentuckypostnews.com - August 18 at 9:32 PM
	Will Core Laboratories N.V. (NYSE:CLB) Hit $150 Price Target? - Investor Newswire (NYSE:CLB) www.investornewswire.com - August 18 at 9:32 PM
	Will Core Laboratories’ Strategies Improve Returns? (NYSE:CLB) marketrealist.com - August 17 at 4:22 PM
	How Volatile Is Core Laboratories Now? (NYSE:CLB) marketrealist.com - August 17 at 10:59 AM
	Returns of Oilfield Services Stocks with High Implied Volatility (NYSE:CLB) marketrealist.com - August 17 at 10:59 AM
	3 Oil Stocks to Buy in August (NYSE:CLB) www.fool.com - August 16 at 1:53 PM
	Core Laboratories’ Short Interest Is Increasing, but What Will That Mean? (NYSE:CLB) marketrealist.com - August 16 at 9:17 AM
	Is Core Laboratories Overvalued at Current Levels? (NYSE:CLB) marketrealist.com - August 15 at 11:30 AM
	Is Core Laboratories Currently Overvalued versus Peers? (NYSE:CLB) marketrealist.com - August 15 at 11:30 AM
	What Are Core Laboratories’ Plans for Its Free Cash Flow? (NYSE:CLB) marketrealist.com - August 12 at 11:38 AM
	Is Core Laboratories Planning a Share Buyback? (NYSE:CLB) marketrealist.com - August 12 at 11:38 AM
	How Much Debt Has Core Laboratories Reduced in 1H16? (NYSE:CLB) marketrealist.com - August 11 at 11:32 AM
	Will Rig Count Affect Core Laboratories in 3Q16? (NYSE:CLB) marketrealist.com - August 10 at 4:19 PM
	Core Laboratories N.V. Common S (CLB) Position Increased by Kayne Anderson Rudnick Investment Management ... - Finance Daily (NYSE:CLB) www.fidaily.com - August 9 at 10:40 PM
	Is Core Laboratories' Share Price Still Bullish? - Market Realist (NYSE:CLB) marketrealist.com - August 9 at 5:14 PM
	What’s the Correlation between Core Laboratories’ Stock and Crude Oil? (NYSE:CLB) marketrealist.com - August 9 at 5:14 PM
	Core Laboratories NV (NYSE:CLB) Quarterly Dividend At $-46.837 Millions - Stocks Daily (NYSE:CLB) www.stocksdaily.net - August 6 at 4:40 PM
	Citigroup Maintains Core Laboratories N.V. to Neutral with Price Target $118.00 - Trade Calls (NYSE:CLB) www.tradecalls.org - August 2 at 9:02 AM
	Revenue Update on Core Laboratories N.V.(NYSE:CLB) - Trade Calls (NYSE:CLB) www.tradecalls.org - July 29 at 8:04 AM
	Can Shares Of Core Laboratories N.V. (NYSE:CLB) Hit $150? - Investor Newswire (NYSE:CLB) www.investornewswire.com - July 28 at 5:19 PM
	CORE LABORATORIES N V Financials (NYSE:CLB) finance.yahoo.com - July 28 at 1:04 PM
	ETF’s with exposure to Core Laboratories NV : July 26, 2016 (NYSE:CLB) www.capitalcube.com - July 26 at 12:44 PM
	Is This The News Oil Investors Have Been Waiting For? (NYSE:CLB) www.fool.com - July 24 at 7:00 AM
	Earnings Roundup: Colfax Corporation (NYSE:CFX), Core Laboratories N.V. (NYSE:CLB), Valley National Bancorp ... - Engelwood Daily (NYSE:CLB) www.engelwooddaily.com - July 23 at 8:31 AM
	Shares Stumbling of Late: Core Laboratories NV (NYSE:CLB) - TGP (NYSE:CLB) telanaganapress.com - July 23 at 8:31 AM
	CORE LABORATORIES N V Files SEC form 10-Q, Quarterly Report (NYSE:CLB) biz.yahoo.com - July 22 at 4:08 PM
	Core Laboratories NV :CLB-US: Earnings Analysis: Q2, 2016 By the Numbers : July 22, 2016 (NYSE:CLB) www.capitalcube.com - July 22 at 12:33 PM
	Is $150 Price Target Attainable For Core Laboratories N.V. (NYSE:CLB)? - Investor Newswire (NYSE:CLB) www.investornewswire.com - July 22 at 11:57 AM